S1090 HCPCS Level II code: Mometasone furoate sinus implant, 370 micrograms

CMS terminated S1090: its last date of service was Sep 30, 2019. It stays here for looking up older claims; newer services need a current code.

Official description

S1090

Mometasone furoate sinus implant, 370 micrograms

Short description: Mometasone sinus implant

HCPCS · United States

Medicare details

The indicators CMS publishes with S1090 in its October 2026 file. They describe Medicare’s handling, not another payer’s.

Medicare coverage
Not payable by Medicare
Medicare pricing
Service not separately priced by Part B (e.g., services not covered, bundled, used by Part A only, etc.)
Type of service
Other medical items or services
BETOS category
Undefined codes
Added
Jul 1, 2012
Terminated after
Sep 30, 2019

Where S1090 sits

  1. 1S codesTemporary national codes (non-Medicare)
  2. 2Terminated S1090Mometasone furoate sinus implant, 370 micrograms

Source and release

Data release
HCPCS Level II · October 2026
Effective date
Oct 1, 2026
Publisher
CMS

This page is built from the HCPCS Level II catalog that Vero Codes reads when it suggests codes: Centers for Medicare & Medicaid Services’s October 2026 release, imported from the publisher’s file and checked against it. The description, notes and structured data come from the same record.

Frequently asked questions

Is HCPCS code S1090 still valid?

No. CMS terminated S1090; its last date of service was Sep 30, 2019. It is listed for looking up services from before then. Use a current code for newer services.

Does Medicare cover S1090?

CMS lists S1090’s Medicare coverage as “Not payable by Medicare” and its pricing as “Service not separately priced by Part B (e.g., services not covered, bundled, used by Part A only, etc.)”. Coverage and payment still depend on the patient, the setting, the documentation and the payer.

Which HCPCS Level II release does this page use?

It uses CMS’s October 2026 release, in effect from Oct 1, 2026 to Dec 31, 2026. It is a reference: confirm the code against the current list and the payer’s rules before you submit it.